Dr. Phillip A. Erwin, MD

Dr. Erwin practices at Boca Raton Regional Hospital in Boca Raton, Florida, part of Baptist Health South Florida.

Dr. Erwin's NPI, 1356546881, was assigned on June 15, 2007. Dr. Erwin graduated from Harvard Medical School in 2007. Dr. Erwin's Colorado license number on file is 0065583.

Dr. Erwin's primary practice is Boca Raton Regional Hospital, at 800 Meadows Rd, Boca Raton, FL 33486 in Palm Beach County. The practice phone is (561) 955-4200.

Dr. Erwin's primary practice is Boca Raton Regional Hospital in Boca Raton, Florida, part of Baptist Health South Florida. Dr. Erwin is also affiliated with Delray Medical Center. The medical group on file is Baptist Outpatient Center. Dmand AI also links Dr. Erwin to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Erwin practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Erwin's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Erwin is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Erwin's licenses on file in 6 states: Colorado, Florida, New York, Ohio, South Carolina and Massachusetts.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, chronic hypertension, coronary artery disease and heart failure among the conditions Dr. Erwin treats.

CMS data shows 5,286 Medicare services from Dr. Erwin across 30 procedure codes in 2024, for 833 Medicare patients. Medicare paid $448,823 for them.

CMS counts 833 Medicare patients who saw Dr. Erwin in 2024. The largest group is 75 to 84, with 330 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Erwin's median patient age at 70, with 45% women.

In 2024, Dr. Erwin wrote 1,906 Medicare Part D claims for 451 patients. 82% of them were for generic drugs. CMS names the drug for 1,665 of them, across 37 drugs with 11 or more claims each, at $354,530 in total drug cost. In 2023, CMS named 650 claims across 22 drugs.

Dr. Erwin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Erwin as offering telehealth. CMS counts 17 procedures of coronary angioplasty and stenting by Dr. Erwin, more than 44% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Erwin, published from 2003 to 2016. 2014 was the busiest year, with 3. The most frequent topics are Endothelium, Vascular, Fibromuscular Dysplasia and Cattle. Dr. Erwin has published most often in J Biol Chem. Dr. Erwin's most frequent co-authors are Joseph Vincent Valentino Blas, MD, Sagar S. Gandhi, MD and Surafel Kebede Gebreselassie, MD.

Dmand AI links Dr. Erwin to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Intermittent Claudication and Peripheral Arterial Disease.

CMS Open Payments shows 280 general payments to Dr. Erwin from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 70% of the total. Medtronic Vascular, Inc. paid the most, $4,124.

Dr. Erwin graduated from Harvard Medical School in 2007. Dr. Erwin is a member of ACC.

Dr. Erwin is in network with 18 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.